Instruction for use: Ormidol

Trade name of the drug – Ormidol

Dosage Form: tablets

Active substance: Atenololum

ATX

C07AB03 Atenolol

Pharmacotherapeutic group: Beta-blockers

The nosological classification (ICD-10)

C74 Malignant neoplasm of adrenal gland: Glyukosteroma; corticosteroma; inoperable corticosteroma; Tumors of the adrenal gland

E05 Thyrotoxicosis [hyperthyroidism]: Von Basedow's disease; Basedow's disease; hyperthyroidism; Goitre diffuse toxic; Increased thyroid function; tireotoksicski reaction; Toxic diffuse goiter; Toxic goiter; Enlargement of the thyroid gland with symptoms of hyperthyroidism; The phenomenon of iodine Basedow

G43 Migraine: The pain of migraine; Migraine; hemiplegic migraine; Migraine headache; A migraine attack; Continuous headache; hemicrania

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I25.2 Transferred last myocardial infarction: Cardiac syndrome; Myocardial infarction; post-MI; Rehabilitation after myocardial infarction; Reocclusion of the operated vessel; Angina postinfarctnaya; Status after myocardial infarction; Status after myocardial infarction; myocardial infarction

I42.1 Obstructive hypertrophic cardiomyopathy: Asymmetrical hypertrophy of the interventricular septum; Hypertrophic obstructive cardiomyopathy; Obliteriruschaya restrictive cardiomyopathy; Hypertrophic cardiomyopathy; Hypertrophic obstructive cardiomyopathy; Myocardial hypertrophy with obstruction

I47.1 Supraventricular tachycardia: Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmia; supraventricular tachycardia; Supraventricular arrhythmias; Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmias; supraventricular tachycardia; Neurogenic sinus tachycardia; orthodromic tachycardia; Paroxysmal supraventricular tachycardia; Paroxysm of supraventricular tachycardia; Paroxysm of supraventricular tachycardia with WPW-syndrome; Paroxysm of atrial tachycardia; Paroxysmal supraventricular tachyarrhythmia; Paroxysmal supraventricular tachycardia; Politopnye atrial tachycardia; Atrial fibrillation; Atrial tachycardia is true; Atrial tachycardia; Atrial tachycardia with AV block; reperfusion arrhythmias; Reflex Bertsolda-Jarisch; Recurrent sustained supraventricular paroxysmal tachycardia; Symptomatic ventricular tachycardia; Sinus tachycardia; Supraventricular paroxysmal tachycardia; supraventricular tachyarrhythmia; supraventricular tachycardia; supraventricular arrhythmia; supraventricular arrhythmias; Tachycardia of AV connections; supraventricular tachycardia; Tachycardia orthodromic; sinus tachycardia; The nodal tachycardia; Chaotic atrial tachycardia politopnye; Wolff-Parkinson-White

I47.2 Ventricular tachycardia: Torsades de pointes (torsade de pointes); Symptomatic ventricular tachycardia; Torsades de pointes in myocardial infarction; Ventricular fibrillation; Ventricular tachycardia; Ventricular tachyarrhythmias; Ventricular tachycardia; ventricular Tachycardia; Life-threatening ventricular arrhythmias; Sustained ventricular tachycardia; Sustained monomorphic ventricular tachycardia; Paroxysmal ventricular tachycardia torsades; Paroxysmal ventricular tachycardia

I49.9 Irregular heartbeat, unspecified: Paroxysmal supraventricular tachycardia; extrasystole arrhythmia; Atrial fibrillation tachysystolic; supraventricular tachyarrhythmia; supraventricular arrhythmias; AV reciprocating tachycardia; AV-nodal reciprocating tachycardia; ventricular fibrillation; Irregular heartbeat; Antidromic reciprocating tachycardia; Cardiac arrhythmias; Arrhythmias; Arrhythmia; Heart arythmy; Arrhythmia due to hypokalemia; ventricular tachyarrhythmias; The high frequency of ventricular contraction; Cardiac arrhythmias; Paroxysmal supraventricular arrhythmia; Paroxysmal supraventricular arrhythmia; Paroxysmal dysrhythmia; Paroxysmal atrial-ventricular rhythm; cardiac arrhythmias; supraventricular tachycardia; tachyarrhythmia; Precordial abnormal pulsation

R07.2 Pain in the heart: neuroses of the heart; Myocardial ischemic pain; Pain syndrome in myocardial infarction; cardialgia; cardioneurosis; Cardiac syndrome; Pain in cardiac patients; Cardialgia on background dyshormonal myocardial dystrophy; Functional cardialgia; Psevdostenokardiya; pericardial pain

R25.1 Tremor, unspecified: shake; senile tremor; Tremor; muscle tremors; Tremor when portal-systemic encephalopathy; Essential tremor family; Titubatsiya

Composition (per tablet): 1 coated tablet contains 100 mg of atenolol; Blister of 14 pcs., in box 1 pack.

Pharmacological Properties of Ormidol

Pharmachologic effect - antianginal, hypotensive, anti-arrhythmic.

Blocks beta1-adrenergic receptors.

Indications for Ormidol

Hypertension, angina, arrhythmias (supraventricular, ventricular tachycardia), prevention of recurrent myocardial infarction, hypertrophic cardiomyopathy, pheochromocytoma (adjuvant), migraine (prevention), tremor, hyperthyroidism (an adjuvant), mitral valve prolapse syndrome.

Contraindications for Ormidol

Hypersensitivity, heart failure (refractory to cardiac glycosides), cardiogenic shock, AV block II or III degree, sinus bradycardia (heart rate less than 45 beats per minute), hypotension (systolic blood pressure below 100 mm Hg).

Side effect of Ormidol

Weakness, headache, sleep disturbance, drowsiness, depression, lethargy, bradycardia, decreased cardiac output, heart failure, depression of AV conduction, vasculitis, postural hypotension, leg pain, aggravation of Raynaud's syndrome, nausea, diarrhea, shortness of breath, reduced tolerance glucose, agranulocytosis, purpura, rash.

Interaction

Blockers of slow calcium channels may enhance the hypotensive and negative chrono and Dromotropic. In an application with sympathomimetics, xanthine (especially aminophylline and theophylline) may weaken the effect of the mutual.

Dosage and Administration

Inside, hypertension - at an initial dose of 50 mg 1 time per day, 2 weeks dose increase (if necessary) to 100 mg; angina initial dose - 50 mg 1 time per day, 1 week dose can be increased to 100 mg per day; after myocardial infarction - 1 100 mg once a day; those remaining - an initial dose of 50 mg once a day 1, and then - to 200 mg per day. When kidney function is dependent on the dose of Cl creatinine: 15-35 ml / min - 50 mg per day, less than 15 ml / min - 50 mg every second day.

Storage conditions of Ormidol

In a dry, dark place at room temperature.

Keep out of the reach of children.

Shelf life

5 years.

Do not use beyond the expiration date printed on the package.